Pd-L1 Assay Elisa

Lab Reagents

Assay Elisa Laboratories manufactures the pd-l1 assay elisa reagents distributed by Genprice. The Pd-L1 Assay Elisa reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Assay elisa. Other Pd-L1 products are available in stock. Specificity: Pd-L1 Category: Assay Group: Elisa

Elisa information

PD-1/PD-L1 inhibitor 1
B6172-5 5 mg
EUR 168
Description: IC50: 0.006-0.10 ?MPD-1/PD-L1 inhibitor 1 is a PD-1/PD-L1 interaction inhibitor.Plenty of studies show that blocking the PD-1/PD-Ll interactions can lead to the restorage and augment of T cell activation in many systems.

Human PD-L1 Elisa Kit
QY-E05642 96T
EUR 361

Anti-PD-L1 Antibody
A1454-100
EUR 338

Anti-PD-L1 Antibody
A1454-30T
EUR 146

PD-L1 (CD274) siRNA
20-abx910978
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol

PD-L1 (CD274) siRNA
20-abx910979
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol

PD-L1 Blocking Peptide
20-abx161326
  • EUR 272.00
  • EUR 411.00
  • 1 mg
  • 5 mg

PD-L1 Rabbit pAb
A1645-100ul 100 ul
EUR 308

PD-L1 Rabbit pAb
A1645-200ul 200 ul
EUR 459

PD-L1 Rabbit pAb
A1645-20ul 20 ul
EUR 183

PD-L1 Rabbit pAb
A1645-50ul 50 ul
EUR 223

PD-L1 Rabbit pAb
A11273-100ul 100 ul
EUR 308

PD-L1 Rabbit pAb
A11273-200ul 200 ul
EUR 459

PD-L1 Rabbit pAb
A11273-20ul 20 ul
EUR 183

PD-L1 Rabbit pAb
A11273-50ul 50 ul
EUR 223

Mouse PD-L1 Antibody
32903-05111 150 ug
EUR 261

Anti-PD-L1 antibody
STJ130022 50 µl
EUR 321
Description: Programmed death-ligand 1 (PD-L1) is a 40kDa type 1 transmembrane protein that suppresses immune system. PD-L1 is expressed in hematopoietic and nonhematopoietic cells including T cells and B cells and various types of tumor cells. PD-L1 binds to its receptor Programmed death 1 (PD1). During infection or inflammation, PD1PD-L1 interaction is important for preventing autoimmunity. In tumor microenvironments, PD1-PD-L1 interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human cancers. In recent years, PDL1 has become an important biomarker and immunotherapy target for many types of malignancies.